2.
单项血清肿瘤标志物检测（国际）
Detection of the single tumor marker in serum (international)
| Biomarker | Diagnosis | Reference | Patients | Controls | Sensitivity | Specificity | Accuracy |
| CEA | SCLC, NSCLC, adenoCA | 43 | 5 425 | 2 058 | 33.23% | 89.56% | 48.72% |
| CA125 | SCLC, NSCLC, adenoCA | 9 | 1 907 | 382 | 28.51% | 88.67% | 38.55% |
| CYFRA21-1 | NSCLC, SCC | 51 | 9 737 | 6 301 | 46.96% | 91.37% | 64.41% |
| TPA | NSCLC, SCC | 18 | 2 242 | 1 405 | 51.16% | 86.90% | 64.93% |
| SCCAg | NSCLC, SCC | 14 | 2 029 | 955 | 29.71% | 96.93% | 51.22% |
| NSE | SCLC | 23 | 2 641 | 1 593 | 43.31% | 90.76% | 61.16% |
| ProGRP | SCLC | 6 | 883 | 722 | 57.08% | 91.69% | 72.64% |
| CA19-9 | SCLC, NSCL | 2 | 93 | 72 | 72.04% | 84.72% | 77.11% |
| CA153 | SCLC, NSCL | 2 | 76 | 60 | 68.42% | 83.33% | 75.00% |
| Ferrtin | SCLC, NSCL | 4 | 306 | 102 | 48.69% | 68.62% | 53.68% |
| GSF | SCLC, NSCL | 2 | 112 | 68 | 66.07% | 67.85% | 72.61% |
| M-CSF | SCLC, NSCL | 2 | 112 | 68 | 56.25% | 39.70% | 50.00% |
| DKK1 | SCLC, NSCL | 0 | 0 | 0 | 0 | 0 | 0 |